Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 23, 2000

View Archived Issues

NIH grant for acute lung injury research goes to CollaGenex

Interferon Sciences acquires option to purchase 50% of Metacine stock

Oncophage enters phase II sarcoma study; trial marks drug's seventh cancer indication

Lilly terminates (R)-fluoxetine license agreement with Sepracor

TroVax colorectal cancer vaccine approved for phase I/II

FDA grants priority review status for pulmonary hypertension NDA

Celebrex introduced in major European market

Interim data from AIDS dementia complex trial of CPI-1189 announced

DuPont designs novel template-constrained cyclic peptide somatostatin analogues

Active enantiomers of new thiourea NNRTIs effective against resistant HIV strains

Long-acting subdermal contraceptive implant now available in Germany

Antitumor activity and mechanism of action of new Hsp90 inhibitor examined in preclinical studies

Encouraging data reported for Emitasol in diabetic gastroparesis

G207 studied further for anticancer, antimetastatic potential

Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion

Coley begins phase II trials with CpG compound

SmithKline Beecham exercises development option for HGS compound

MDR-reversing pyripyropene characterized at Japanese Cancer Association meeting

SkyePharma's Solaraze earns FDA approval

Orally active plant-derived peptide with hypoglycemic activity

Vivus withdraws Alibra NDA

Novel anthracyclines designed by Menarini display excellent antitumor activity

Italian scientists discover antitumor agents particularly useful in colon cancer

Sankyo's new therapeutics for Alzheimer's disease display dual actions

NK1 receptor antagonists useful for CNS disorders reported by Roche

Pharmacia identifies new herpesvirus polymerase inhibitors

Imidazole-based H3 receptor antagonists and their use patented by Schering-Plough

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...